Why the study?
Does volume therapy improve hemodynamic and rheological parameters in patients with acute ischemic stroke?
Does volume therapy improve hemodynamic and rheological parameters in patients with acute ischemic stroke?
Answers are grounded in this paper and cite their sources.
Volume therapy with newer hydroxyethyl starches may safely improve hemodynamics and rheology in acute ischemic stroke without increasing hemorrhage risk.
SUMMARY In acute ischemic stroke, because of impaired autoregulation, the perfusion of the ischemic brain region and its neighboring region, the penumbra, depends on blood pressure, cardiac output and rheological characteristics. Improvement of rheological parameters and hemodynamics is therefore a promising therapeutic strategy for ischemic stroke. Volume therapy in acute ischemic stroke attempts to increase cardiac output and blood pressure by increasing cardiac preload through the infusion of colloid and crystalloid solutions. Another important therapeutic avenue is the improvement of rheology through a decrease in hematocrit, plasma viscosity and erythrocyte aggregation. The adequate choice of plasma substitutes allows for a more differentiated volume therapy in acute stroke. With newer, medium‐ or low‐molecular weight hydroxyethyl starches, it is possible to safely use a high‐dose, hemodynamic volume therapy in acute ischemic stroke and improve hemodynamic and rheological parameters without increased risk of hemorrhages.
No takes yet. Share an insight, caveat, or question.
Mt et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: